DIN 02532530 — UBRELVY 50 MG
UBRELVY is a tablet of Ubrogepant marketed by ABBVIE CORPORATION. The full Ubrogepant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02532530
- Brand name
- UBRELVY
- Active ingredient
- Ubrogepant
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Calcitonin gene-related peptide (CGRP) receptor antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ubrogepant products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02532581 | UBRELVY | 100 MG | TABLET | ABBVIE CORPORATION | MARKETED |